Biogen Idec to Present at the 2009 Annual Credit Suisse Healthcare Conference

* Reuters is not responsible for the content in this press release.

Mon Nov 9, 2009 5:35pm EST 

CAMBRIDGE, Mass.--(Business Wire)--
Biogen Idec Inc. (NASDAQ:BIIB) announced today that its presentation at the 2009
Annual Credit Suisse Healthcare Conference will be webcast live via the
internet, on Friday, November 13, 2009 at 8:30 a.m. MST, 6:30 a.m. EST. To
access the live webcast, please visit Biogen Idec`s Investor Relations section
(investor.biogenidec.com). An archived version of the webcast will be available
for 14 days following the presentation. 

About Biogen Idec

Biogen Idec creates new standards of care in therapeutic areas with high unmet
medical needs. Biogen Idec is a global leader in the discovery, development,
manufacturing, and commercialization of innovative therapies. Patients in more
than 90 countries benefit from Biogen Idec's significant products that address
diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. For
product labeling, press releases and additional information about the company,
please visit www.biogenidec.com.

Biogen Idec
Karen Jewell, 617-679-2757
Investor Relations 



Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.